Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study
Emerging Classic

The randomized AMBORA trial: impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents.

Dürr P, Schlichtig K, Kelz C, et al. The randomized AMBORA trial: impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents. J Clin Oncol. 2021;39(18):1983-1994. doi:10.1200/jco.20.03088.

Save
Print
April 21, 2021
Dürr P, Schlichtig K, Kelz C, et al. J Clin Oncol. 2021;39(18):1983-1994.
View more articles from the same authors.

Patients taking oral anti-cancer drugs may experience severe side effects and medication errors. In this randomized controlled study, patients taking oral chemotherapy drugs were randomized to receive usual care (control) or additional intensive pharmacological/pharmaceutical care (intervention). Patients in the intervention group reported considerably fewer medication errors and side effects and increased treatment satisfaction.

Save
Print
Cite
Citation

Dürr P, Schlichtig K, Kelz C, et al. The randomized AMBORA trial: impact of pharmacological/pharmaceutical care on medication safety and patient-reported outcomes during treatment with new oral anticancer agents. J Clin Oncol. 2021;39(18):1983-1994. doi:10.1200/jco.20.03088.